The Registry of Toxic Effects of Chemical Substances
Pyrocatechol |
UPDATE: May 2005 | MW: 110.12 | MF: C6H6O2 |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
hamster
embryo
|
3 µmol/L
|
MUREAV 373,113,1997
|
cytogenetic analysis
|
hamster
ovary
|
50 mg/L
|
CALEDQ 14,251,1981
|
cytogenetic analysis
|
hamster
lung
|
60 µmol/L/2 hour
|
MUREAV 540,29,2003
|
DNA damage
|
human
lymphocyte
|
100 µmol/L
|
EMMUEG 26,305,1995
|
DNA damage
|
mouse
lymphocyte
|
500 µmol/L
|
MUREAV 203,155,1988
|
DNA damage
|
other microorganisms
|
10 mmol/L
|
MUREAV 368,235,1996
|
DNA damage
|
rat
liver
|
3 mmol/L
|
CALEDQ 63,47,1992
|
DNA inhibition
|
human
HeLa cell
|
200 µmol/L
|
MUREAV 92,427,1982
|
DNA inhibition
|
mouse
lymphocyte
|
250 µmol/L
|
MOPMA3 28,560,1985
|
DNA repair
|
Bacillus subtilis
|
500 mg/L
|
ESKGA2 32,171,1986
|
unscheduled DNA synthesis
|
hamster
embryo
|
1 µmol/L
|
MUREAV 373,113,1997
|
unscheduled DNA synthesis
|
oral | rat
1 gm/kg
|
JJIND8 74,1283,1985
|
mutation in microorganisms
|
Escherichia coli
|
2 mg/plate (-enzymatic activation step)
|
MUREAV 467,41,2000
|
mutation in microorganisms
|
Salmonella typhimurium
|
15 µmol/plate (+enzymatic activation step)
|
PAACA3 20,117,1979
|
mutation in microorganisms
|
Salmonella typhimurium
|
4 µg/plate (-enzymatic activation step)
|
ABCHA6 45,327,1981
|
micronucleus test
|
hamster
lung
|
25 µmol/L
|
EVHPAZ 82,81,1989
|
micronucleus test
|
oral | mouse
40 mg/kg
|
MUREAV 208,61,1988
|
micronucleus test
|
intraperitoneal | mouse
10 mg/kg
|
MUREAV 341,29,1994
|
gene conversion and mitotic recombination
|
Aspergillus nidulans
|
10 mmol/L
|
MUTAEX 2,235,1987
|
gene conversion and mitotic recombination
|
Saccharomyes cerevisiae
|
300 mg/L
|
MUREAV 135,109,1984
|
mutation in mammalian somatic cells
|
hamster
embryo
|
10 µmol/L
|
MUREAV 373,113,1997
|
mutation in mammalian somatic cells
|
mouse
lymphocyte
|
2,500 µg/L
|
EMMUEG 11,523,1988
|
morphological transform
|
hamster
embryo
|
1 µmol/L
|
MUREAV 373,113,1997
|
morphological transform
|
mouse
other cell types
|
0.25 mg/L/12 day
|
MUREAV 557,191,2004
|
other mutation test systems
|
human
lymphocyte
|
40 µmol/L
|
CNREA8 40,1189,1980
|
other mutation test systems
|
rabbit
bone marrow
|
2 mmol/L
|
AJIMD8 7,485,1985
|
sister chromatid exchange
|
hamster
lung
|
12,500 nmol/L
|
EVHPAZ 82,81,1989
|
sister chromatid exchange
|
hamster
embryo
|
10 µmol/L
|
MUREAV 373,113,1997
|
sister chromatid exchange
|
human
lymphocyte
|
40 µmol/L
|
CNREA8 40,1189,1980
|
sex chromosome loss and nondisjunction
|
hamster
embryo
|
30 µmol/L
|
MUREAV 373,113,1997
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | rat
lowest published toxic dose: 1 gm/kg (11 day pregnant)
|
Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth)
|
TJADAB 41,43,1990
|
subcutaneous | rat
lowest published toxic dose: 5 mg/kg (1 day prior to copulation)
|
Reproductive: Maternal effects: Ovaries, fallopian tubes
|
ENDOAO 57,466,1955
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | mouse
lowest published toxic dose: 645 gm/kg/96 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Gastrointestinal: Tumors
JJCREP 81,207,1990
|
oral | mouse
lowest published toxic dose: 3,696 mg/kg/44 week- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Tumorigenic: Facilitates action of known carcinogens Gastrointestinal: Tumors
CALEDQ 139,167,1999
|
oral | rat
lowest published toxic dose: 437 gm/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Gastrointestinal: Tumors
JJCREP 81,207,1990
|
oral | rat
toxic dose : 60,640 mg/kg/24 week- continuous
|
Tumorigenic: Neoplastic by RTECS criteria | Gastrointestinal: Tumors
JJCREP 77,854,1986
|
oral | rat
toxic dose : 349 gm/kg/2 year- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Gastrointestinal: Tumors
FCTOD7 33,93,1995
|
oral | rat
lowest published toxic dose: 171 gm/kg/51 week- continuous
|
Tumorigenic: Carcinogenic by RTECS criteria | Gastrointestinal: Tumors
JJCREP 85,17,1994
|
oral | rat
lowest published toxic dose: 7,854 mg/kg/34 week- intermittent
|
Tumorigenic: Neoplastic by RTECS criteria | Gastrointestinal: Tumors
JTPAE7 29,180,2001
|
oral | rat
lowest published toxic dose: 102,648 mg/kg/104 week- intermittent
|
Tumorigenic: Carcinogenic by RTECS criteria | Gastrointestinal: Tumors
JTPAE7 29,180,2001
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | guinea pig
lowest published lethal dose: 150 mg/kg
|
N/R
|
HBTXAC 1,62,1955
|
intraperitoneal | guinea pig
lowest published lethal dose: 150 mg/kg
|
Behavioral: Ataxia | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVGK* -,224,1994
|
intraperitoneal | mouse
lethal dose (50 percent kill): 68 mg/kg
|
N/R
|
PHTOEH 64,247,1989
|
intraperitoneal | mouse
lethal dose (50 percent kill): 190 mg/kg
|
Behavioral: Ataxia | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVGK* -,224,1994
|
intravenous | cat
lowest published lethal dose: 100 mg/kg
|
Behavioral: Ataxia | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVGK* -,224,1994
|
intravenous | dog
lowest published lethal dose: 40 mg/kg
|
N/R
|
HBTXAC 1,62,1955
|
intravenous | dog
lowest published lethal dose: 40 mg/kg
|
Behavioral: Ataxia | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVGK* -,224,1994
|
oral | cat
lethal dose (50 percent kill): 100 mg/kg
|
N/R
|
IPSTB3 3,93,1976
|
oral | dog
lethal dose (50 percent kill): 130 mg/kg
|
N/R
|
IPSTB3 3,93,1976
|
oral | dog
lowest published lethal dose: 130 mg/kg
|
Behavioral: Ataxia | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVGK* -,224,1994
|
oral | guinea pig
lethal dose (50 percent kill): 210 mg/kg
|
N/R
|
AFREAW 3,197,1951
|
oral | mammal (species unspecified)
lethal dose (50 percent kill): 240 mg/kg
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Muscle contraction or spasticity Lung, Thorax, or Respiration: Dyspnea
TPKVAL 15,136,1979
|
oral | mouse
lethal dose (50 percent kill): 260 mg/kg
|
N/R
|
AFREAW 3,197,1951
|
oral | mouse
lethal dose (50 percent kill): 100 mg/kg
|
Behavioral: Ataxia | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVGK* -,224,1994
|
oral | rat
lethal dose (50 percent kill): 260 mg/kg
|
N/R
|
AFREAW 3,197,1951
|
oral | rat
lethal dose (50 percent kill): 3,890 mg/kg
|
Behavioral: Ataxia | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVGK* -,224,1994
|
oral | rabbit
lowest published lethal dose: 200 mg/kg
|
Behavioral: Altered sleep time (including change in righting reflex) | Blood: Luekopenia Blood: Methemoglobinemia- Carboxhemoglobinemia
38MKAJ 2A,2585,1981
|
oral | rabbit
lowest published lethal dose: 1,000 mg/kg
|
Behavioral: Ataxia | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVGK* -,224,1994
|
parenteral | frog
lowest published lethal dose: 160 mg/kg
|
Peripheral Nerve and Sensation: Spastic paralysis with/without sensory change | Behavioral: Convulsions or effect on seizure threshold
AEPPAE 166,437,1932
|
subcutaneous | frog
lowest published lethal dose: 160 mg/kg
|
N/R
|
HBTXAC 1,62,1955
|
subcutaneous | guinea pig
lowest published lethal dose: 200 mg/kg
|
N/R
|
HBTXAC 1,62,1955
|
subcutaneous | guinea pig
lowest published lethal dose: 200 mg/kg
|
Behavioral: Ataxia | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVGK* -,224,1994
|
subcutaneous | mouse
lethal dose (50 percent kill): 247 mg/kg
|
N/R
|
INHEAO 5,143,1967
|
subcutaneous | mouse
lethal dose (50 percent kill): 247 mg/kg
|
Behavioral: Ataxia | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVGK* -,224,1994
|
subcutaneous | rat
lowest published lethal dose: 110 mg/kg
|
N/R
|
AIPTAK 176,193,1968
|
subcutaneous | rat
lowest published lethal dose: 200 mg/kg
|
Behavioral: Ataxia | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVGK* -,224,1994
|
subcutaneous | rabbit
lowest published lethal dose: 225 mg/kg
|
N/R
|
JAFCAU 17,497,1969
|
skin | rabbit
lethal dose (50 percent kill): 800 mg/kg
|
Skin: After topical application: Primary irritation | Nutritional and Gross Metabolic: Weight loss or decreased weight gain
AIHAAP 37,596,1976
|
skin | rabbit
lethal dose (50 percent kill): 800 mg/kg
|
Behavioral: Ataxia | Behavioral: Tetany Lung, Thorax, or Respiration: Dyspnea
VCVGK* -,224,1994
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lowest published toxic dose: 450 mg/kg/3 day- intermittent
|
Blood: Changes in bone marrow not included in above | Blood: Changes in spleen
VCVGK* -,225,1994
|
intravenous | mouse
lowest published toxic dose: 450 mg/kg/3 day- intermittent
|
Blood: Changes in bone marrow not included in above | Blood: Changes in spleen
VCVGK* -,225,1994
|
oral | chicken
lowest published toxic dose: 98 gm/kg/4 week- intermittent
|
Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
|
FEPRA7 29,568,1970
|
oral | rat
lowest published toxic dose: 15,470 mg/kg/34 week- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol)
|
JTPAE7 29,180,2001
|
oral | rat
lowest published toxic dose: 2,226 mg/kg/7 day- intermittent
|
Nutritional and Gross Metabolic: Weight loss or decreased weight gain
|
JTPAE7 29,180,2001
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
time-weighted average 5 ppm (skin)
|
DTLVS* TLV/BEI,2003
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value
|
Confirmed Animal Carcinogen with Unknown
|
DTLVS* TLV/BEI,2003
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Sufficient Evidence
|
IMEMDT 71,433,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Animal Inadequate Evidence
|
IMEMDT 15,155,1977
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human No Adequate Data
|
IMEMDT 15,155,1977
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Human No Adequate Data
|
IMEMDT 71,433,1999
|
International Agency for Research on Cancer (IARC) Cancer Review
|
Group 2B
|
IMEMDT 71,433,1999
|
TOXICOLOGY REVIEW
|
|
MUREAV 566,99,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,227,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,109,2004
|
TOXICOLOGY REVIEW
|
|
MUREAV 567,151,2004
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - AUSTRALIA
|
time-weighted average 5 ppm (20 mg/m3), JAN1993
|
Occupational Exposure Limit - AUSTRIA
|
MAK 5 pppm (20 mg/m3), JAN1999
|
Occupational Exposure Limit - BELGIUM
|
time-weighted average 5 ppm (23 mg/m3), JAN1993
|
Occupational Exposure Limit - DENMARK
|
time-weighted average 5 ppm (20 mg/m3), JAN1999
|
Occupational Exposure Limit - FINLAND
|
time-weighted average 5 ppm (22 mg/m3), short term exposure limit 10 ppm (45 mg/m3), JAN1999
|
Occupational Exposure Limit - FRANCE
|
VME 5 ppm (20 mg/m3), JAN1999
|
Occupational Exposure Limit - NORWAY
|
time-weighted average 5 ppm (20 mg/m3), JAN1999
|
Occupational Exposure Limit - THE NETHERLANDS
|
MAC-TGG 20 mg/m3, 2003
|
Occupational Exposure Limit - SWITZERLAND
|
MAK- week 5 ppm (23 mg/m3), JAN1999
|
Occupational Exposure Limit - UNITED KINGDOM
|
time-weighted average 5 ppm (23 mg/m3), SEP2000
|
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN, KOREA
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value; | Confirmed Animal Carcinogen with Unknown
Occupational Exposure Limit IN NEW ZEALAND, SINGAPORE, VIETNAM
|
American Conference of Governmental Industrial Hygienists (ACGIH) Threshold Limit Value |
Confirmed Animal Carcinogen with Unknown |
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO CATECHOL-air
|
10 hour time-weighted average 5 ppm (Sk)
|
NIOSH* DHHS #95-121,1995
|
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: M1763; | Number of Industries 4; Total Number of Facilities 147; Number of Occupations 6; Total Number of Employees Exposed 642
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: M1763; |
Number of Industries 8; Total Number of Facilities 700; Number of Occupations 15; Total Number of Employees Exposed 13,516; Total Number of Female Employees Exposed 5,799 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as a chemical intermediate, pharmaceutical and veterinary drug
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
On EPA IRIS database
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
|
REFERENCES:
CODEN
|
|
REFERENCE
38MKAJ
|
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton,
eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2nd
rev. ed. in 1985.
|
ABCHA6
|
Agricultural and Biological Chemistry. (Maruzen Co. Ltd., POB 5050, Tokyo International,
Tokyo 100-31, Japan) V.25- 1961-
|
AEPPAE
|
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.)
V.110-253, 1925-66. For publisher information, see NSAPCC.
|
AFREAW
|
Advances in Food Research. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1-32,
1948-88.
|
AIHAAP
|
American Industrial Hygiene Association Journal. (AIHA, 475 Wolf Ledges Pkwy., Akron, OH
44311) V.19- 1958-
|
AIPTAK
|
Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of
Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898-
|
AJIMD8
|
American Journal of Industrial Medicine. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.1- 1980-
|
CALEDQ
|
Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1975-
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
DTLVS*
|
The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by
American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996
|
EMMUEG
|
Environmental and Molecular Mutagenesis. (Alan R. Liss, Inc., 41 E. 11th St., New York, NY
10003) V.10- 1987-
|
ENDOAO
|
Endocrinology (Baltimore). (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21203)
V.1- 1917-
|
ESKGA2
|
Eisei Kagaku. Hygienic Chemistry. (Nippon Yakugakkai, 2-12-15 Shibuya, Shibuya-ku, Tokyo
150, Japan) V.1- 1953-
|
EVHPAZ
|
EHP, Environmental Health Perspectives. (U.S. Government Printing Office, Supt of Documents,
Washington, DC 20402) No.1- 1972-
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
FEPRA7
|
Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda,
MD) V.1-46, 1942-87.
|
HBTXAC
|
"Handbook of Toxicology," 4 vols., Philadelphia, W.B. Saunders Co., 1956-59
|
IMEMDT
|
IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications
Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
|
INHEAO
|
Industrial Health. (National Institute of Industrial Health, 6-21-1 Nagao, Tama-ku, Kawasaki,
213 Japan) V.1- 1963-
|
IPSTB3
|
International Polymer Science and Technology. (Rapra Technology Ltd., Shawbury, Shrewsbury,
Shropshire SY4 4NR, UK)
|
JAFCAU
|
Journal of Agricultural and Food Chemistry. (American Chemical Soc., Distribution Office
Dept. 223, POB 57136, West End Stn., Washington, DC 20037) V.1- 1953-
|
JJCREP
|
Japanese Journal of Cancer Research. (Elsevier Science Pub. BV, POB 211, 1000 AE Amsterdam,
Netherlands) V.76- 1985-
|
JJIND8
|
JNCI, Journal of the National Cancer Institute. (Washington, DC) V.61-79, 1978-87. For
publisher information, see JNCIEQ.
|
JTPAE7
|
Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi-
shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988
|
MOPMA3
|
Molecular Pharmacology. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202)
V.1- 1965-
|
MUREAV
|
Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1-
1964-
|
MUTAEX
|
Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ,
UK) V.1- 1986-
|
NIOSH*
|
National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and
Welfare, Reports and Memoranda.
|
PAACA3
|
Proceedings of the American Association for Cancer Research. (Waverly Press, 428 E. Preston
St., Baltimore, MD 21202) V.1- 1954-
|
PHTOEH
|
Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016
Copenhagen K, Denmark) V.60- 1987-
|
TJADAB
|
Teratology, The International Journal of Abnormal Development. (Alan R. Liss, Inc., 41 E.
11th St., New York, NY 10003) V.1- 1968-
|
TPKVAL
|
Toksikologiya Novykh Promyshlennykh Khimicheskikh Veshchestv. Toxicology of New Industrial
Chemical Substances. For English translation, see TNICS*. (Izdatel'stvo Meditsina, Moscow,
USSR) No.1- 1961-
|
VCVGK*
|
"Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia".
(Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia,
1994.
|
|